General Information |
|
| NSE Symbol* | REMUS |
| Name of the Company* | REMUS PHARMACEUTICALS LIMITED |
| ISIN* | INE0O5T01011 |
| Type of Meeting |
1) Board Meeting |
| Details of Committee Meeting or Other Type of Meeting | |
| Type of Intimation* | New |
| Reason for Re-schedule (postpone or prepone) / Cancellation | |
| Proposed Meeting Date | 2025-05-17 |
| Original Meeting Date | |
| Whether trading window is closed* | Yes |
| Trading Window Closure- Start date | 2025-04-01 |
| Details of Trading Window Closure End date | 2025-05-19 |
| Short Notice | |
| Date of Report* | 2025-05-12 |
Agenda Details |
|
| Agenda* |
1) Financial results 2) Dividend 3) Other business |
| Whether results are audited or unaudited | Audited |
| Nature of report standalone or consolidated | Standalone And Consolidated |
| Period end Type | Yearly |
| Period up to (Month) | March |
| Period up to (Year) | 2025 |
| Mode of raising Funds | |
| Type of Dividend |
1) Final |
| Remarks (website dissemination) | Further, in this connection, please refer our earlier intimation dated March 27, 2025, whereby, pursuant to the Company’s Code of Conduct framed in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 as amended (“the Code”), the Trading Window for dealing in securities of the Company, for persons specified under the Code, was closed from April 01, 2025 till 48 hours after the Audited Standalone and Consolidated Financial Results of the Company for the half year and financial year March 31, 2025 are approved by the Board of Directors and submitted to Stock Exchange. |